Strategies intended to address vaccine hesitancy: overview of reviews (search up to November 2014) 

Added February 20, 2022

Citation: Dubé E, Gagnon D, MacDonald NE. Strategies intended to address vaccine hesitancy: Review of published reviews. Vaccine. 2015;33(34):4191-203.

Language: Abstract available in EN. Full text available in EN.

Free to view: Yes.

Funding source: Nothing noted specific to this review.

What is this? Multiple vaccines are available for COVID-19 but vaccine hesitancy is proving to be a challenge in some settings. Existing research on vaccine hesitancy might provide useful information for policy makers planning and implementing vaccination programmes for COVID-19 and other infectious diseases.

In this review, the authors searched for reviews of interventions intended to reduce vaccine hesitancy or enhance vaccine acceptance. They restricted their searches to articles published in English between January 2008 and November 2014 and excluded reviews that focused exclusively on strategies to increase influenza vaccine uptake. They included 15 reviews.

What was found: Interventions in the included reviews involved population-based initiatives (e.g. community-based interventions; incentive and rewards; reminders and recalls for vaccination; reminders based on school, college and child care centre requirements); face to face and educational interventions; national immunization initiatives; and social media interventions.

At the time of this review, the authors found no strong evidence to recommend a specific intervention to address vaccine hesitancy or refusal.

Implications: The authors of this review suggested that when vaccine hesitancy interventions are implemented, a rigorous evaluation of their impact on vaccine hesitancy and vaccine acceptance should be included.

Other considerations: The authors of the review discussed their findings in the context of place of residence.

 

This summary was prepared by Stephanie Sampson, edited by Sydney Johnson and finalized by Mike Clarke.

Disclaimer:  This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone. The text can be shared and re-used without charge, citing Evidence Aid as the source and noting the date on which you took the text.

 

الإنكار 免责声明 免責聲明 Disclaimer Clause de non-responsabilité Haftungsausschluss Disclaimer 免責事項 Aviso legal Exención de responsabilidad

Share